Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag
Shares of Option Care Health Inc slid Thursday, after the home and alternate-site infusion provider lowered its full-year revenue outlook—a move that renewed doubts about growth for a business investors had been valuing with expectations of more consistent expansion. The stock slid roughly 28% to $19.44, having earlier hit a session low of $18.04, market data showed. This sharp drop came after first-quarter revenue came in at $1.35 billion, missing analyst estimates of around $1.40 billion, though adjusted earnings per share topped forecasts.